As a Research Nurse in the Drug Development Unit your primary responsibility is to follow study subjects ensuring protocol compliance and close monitoring while the subjects are on study.   

• You will ensure the protection of study patients by timely adherence to protocol requirements and compliance  

• You will use the protocol as the only tool to screen, treat, and follow patients  

• You will ensure that patient documentation is completed at each clinic visit while in screening  

• You will ensure that all medications are approved by the registrar prior to initiating treatment or when changing medication regimens, such as crossover studies  

• You will accurately calculate and documents the BSA, creatinine clearance, urine protein:creatinine ratio or any other conversions needed per protocol  

• You will ensure that follow-up appointments, scans, or any related procedures are scheduled correctly according to protocol requirements  

• You will inform and document appropriate SCRI and clinic personnel when patient comes off study  

You should have for this position:  

• An Associate Degree; preferably a Bachelor’s Degree 

• RN License  

• Knowledge of medical and research terminology 

• Knowledge of FDA Code of Federal Regulations and GCP 

• Knowledge of the clinical research processes 

• At least on year of oncology experience preferred 

• At least one year of experience in a research setting preferred 

• Research Certification (ACRP or CCRP) Preferred 

About Sarah Cannon Research Institute

Sarah Cannon Research Institute (SCRI) is one of the world’s leading oncology research organizations conducting community-based clinical trials. Focused on advancing therapies for patients over the last three decades, SCRI is a leader in drug development. In 2022, SCRI formed a joint venture with former US Oncology Research to expand clinical trial access across the country. It has conducted more than 750 first-in-human clinical trials since its inception and contributed to pivotal research that has led to the majority of new cancer therapies approved by the FDA today. SCRI’s research network brings together more than 1,300 physicians who are actively enrolling patients into clinical trials at more than 250 locations in 24 states across the U.S. Please click here to learn more about our research offerings.

We care about the well-being of the patients and communities we serve, and that starts with caring for our people. That’s why we have a Total Rewards package that includes comprehensive benefits to support physical, mental, and financial well-being. Our Total Rewards offerings serve the different needs of our diverse colleague population and ensure they are the healthiest versions of themselves. For more information regarding benefits through our parent company, McKesson, please click here.

As part of Total Rewards, we are proud to offer a competitive compensation package. This is determined by several factors, including performance, experience and skills, equity, regular job market evaluations, and geographical markets. In addition to base pay, other compensation, such as an annual bonus or long-term incentive opportunities may be offered.